Deciphering genes associated with diffuse large B-cell lymphoma with lymphomatous effusions: A mutational...

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Lymphomatous effusions in diffuse large B-cell lymphoma (DLBCL) are linked to a significantly worse prognosis compared to non-effusion stage IV disease.
• Understanding the genetic underpinnings of lymphomatous effusions is crucial for identifying novel therapeutic targets and oncogenic mechanisms.

Purpose of the Study:

• To investigate genetic abnormalities associated with lymphomatous effusions in DLBCL.
• To identify potential molecular pathways and therapeutic targets implicated in the development of effusions.

Main Methods:

• Whole-exome sequencing was performed on DLBCL samples from solid organs and effusions.
• A mutational accumulation-based approach and mutation interpreters identified candidate pathogenic genes.
• Gene-set enrichment analysis compared effusion-associated and non-effusion-associated DLBCL to identify relevant pathways.

Main Results:

• Genes associated with effusion-based DLBCL were linked to cell migration and invasion.
• Overexpression of HDAC1 and MDM2 proteins correlated with the presence of lymphomatous effusions.
• HDAC1 overexpression was identified as a marker for the poorest prognosis in DLBCL patients with effusions.

Conclusions:

• DLBCL with lymphomatous effusions may be mechanistically linked to the TP53-MDM2 pathway.
• HDAC-related chromatin remodeling mechanisms are implicated in the pathogenesis of lymphomatous effusions.
• HDAC1 and MDM2 represent potential therapeutic targets for DLBCL with effusions.